Open menu Close Previous Next Facebook Twitter LinkedIn YouTube WhatsApp Phone Newsletter Email Location AMSlab AMSvet AMSfood AMSbiopharma CIFGA Nexotech EU

Oncogalfarma

Innovación en biotecnología

New supplementary therapies for the treatment of cancer-related diseases

GalChimia, Oncostellae and AMSLab take part in the research project Oncogalfarma, aiming at developing new supplementary therapies for the treatment of cancer-related diseases. Research is focused on the field of inhibitors of the protein-protein interaction (PPI) and nuclear receptors.

This project is funded by the Regional Government Xunta de Galicia and the ERDF in the framework of the Operational Programme ERDF Galicia 2007-2013 through the sub-programme CONECTA PEME.

Amount of the aid granted: EUR 114,745.76

FEDER
Xunta de Galicia
Axencia Galega de Innovación

Involved companies:

  • AMSlab